2009
DOI: 10.1158/0008-5472.can-08-3489
|View full text |Cite
|
Sign up to set email alerts
|

Association between Transcriptional Activity, Local Chromatin Structure, and the Efficiencies of Both Subpathways of Nucleotide Excision Repair of Melphalan Adducts

Abstract: The repair of melphalan-induced N-alkylpurine monoadducts and interstrand cross-links was examined in different repair backgrounds, focusing on four genes (b-actin, p53, N-ras, and d-globin) with dissimilar transcription activities. Adducts were found to be substrates for both global genome repair (GGR) and transcription-coupled repair (TCR), with TCR being less efficient than GGR. In nucleotide excision repair-deficient cells, adducts accumulated to similar levels in all four genes. The repair efficiency in d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
28
0
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(34 citation statements)
references
References 46 publications
5
28
0
1
Order By: Relevance
“…Gene ontology analyses of Bendamustine treated cells indicated DDR as the top regulated pathway with some evidence that the BER pathway is in part responsible for processing bendamustine induced DNA adducts 58 . While there is also evidence that melphalan mono and di-adducts melphalan are repaired via the NER pathway as demonstrated by the hypersensitivity of NER deficient cells to treatment, 61 this has not been addressed for bendamustine. Bendamustine activation of the DDR has been studied in a few models.…”
Section: Dna Damaging Cancer Therapeuticsmentioning
confidence: 99%
“…Gene ontology analyses of Bendamustine treated cells indicated DDR as the top regulated pathway with some evidence that the BER pathway is in part responsible for processing bendamustine induced DNA adducts 58 . While there is also evidence that melphalan mono and di-adducts melphalan are repaired via the NER pathway as demonstrated by the hypersensitivity of NER deficient cells to treatment, 61 this has not been addressed for bendamustine. Bendamustine activation of the DDR has been studied in a few models.…”
Section: Dna Damaging Cancer Therapeuticsmentioning
confidence: 99%
“…The first mechanism results from the formation of open chromatin structures surrounding a transcribed region, which permits access to repair factors. The second mechanism is initiated by the presence of a stalled elongating RNA polymerase (Laine and Egly 2006; Episkopou et al 2009). The first mechanism would not discriminate between the two DNA strands and would also involve XPC as a recognition factor, whereas the second mechanism would be XPC-independent, CSA- and CSB-dependent, and would repair lesions preferentially on the transcribed strand.…”
Section: Transcription-coupled Icl Repairmentioning
confidence: 99%
“…10 Failure to repair ICLs' lesions before the DNA replication process may induce DNA breaks or chromosomal rearrangements, or lead to cell death. 11 N-alkylpurine-monoadducts are exclusively repaired by nucleotide excision repair (NER), 12 whereas molecular components of NER, Fanconi anemia repair pathway, homologous recombination (HR), nonhomologous end-joining (NHEJ), and translesion synthesis are all required for adequate ICL repair. [13][14][15] DNA double-strand breaks (DSBs) are indirectly formed as a consequence of melphalan-induced oxidative stress, 16 and as intermediates of DNA repair pathways such as base-excision repair and ICL repair.…”
Section: Introductionmentioning
confidence: 99%